Differential effects on sodium current impairments by distinct SCN1A mutations in GABAergic neurons derived from Dravet syndrome patients

Hyun Woo Kim, Zhejiu Quan, Young Beom Kim, Eunji Cheong, Heung Dong Kim, Minjung Cho, Jiho Jang, Young Rang You, Joon Soo Lee, Ji Hun Kim, Yang In Kim, Dae-Sung Kim, Hoon Chul Kang

Research output: Contribution to journalArticle

Abstract

Background: We investigated how two distinct mutations in SCN1A differentially affect electrophysiological properties of the patient-derived GABAergic neurons and clinical severities in two Dravet syndrome (DS) patients. Materials and Methods: We established induced pluripotent stem cells from two DS patients with different mutations in SCN1A and subsequently differentiated them into forebrain GABAergic neurons. Functionality of differentiated GABAergic neurons was examined by electrophysiological recordings. Results: DS-1 patient had a missense mutation, c.4261G > T [GenBank: NM_006920.4] and DS-2 patient had a nonsense frameshift mutation, c.3576_3580 del TCAAA [GenBank: NM_006920.4]. Clinically, contrary to our expectations, DS-1 patient had more severe symptoms including frequency of seizure episodes and the extent of intellectual ability penetration than DS-2 patient. Electrophysiologic recordings showed significantly lower sodium current density and reduced action potential frequency at strong current injection (>60 pA) in GABAergic neurons derived from both. Intriguingly, unique genetic alterations of SCN1A differentially impacted electrophysiological impairment of the neurons, and the impairment's extent corresponded with the symptomatic severity of the donor from which the iPSCs were derived. Conclusion: Our results suggest the possibility that patient-derived iPSCs may provide a reliable in vitro system that reflects clinical severities in individuals with DS.

Original languageEnglish
JournalBrain and Development
DOIs
Publication statusAccepted/In press - 2017 Jan 1

Fingerprint

Myoclonic Epilepsy
GABAergic Neurons
Sodium
Mutation
Nucleic Acid Databases
Induced Pluripotent Stem Cells
Frameshift Mutation
Nonsense Codon
Missense Mutation
Prosencephalon
Action Potentials
Seizures
Tissue Donors
Neurons
Injections

Keywords

  • Dravet syndrome
  • Induced pluripotent stem cell
  • Voltage-gated sodium channel

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Developmental Neuroscience
  • Clinical Neurology

Cite this

Differential effects on sodium current impairments by distinct SCN1A mutations in GABAergic neurons derived from Dravet syndrome patients. / Kim, Hyun Woo; Quan, Zhejiu; Kim, Young Beom; Cheong, Eunji; Kim, Heung Dong; Cho, Minjung; Jang, Jiho; You, Young Rang; Lee, Joon Soo; Kim, Ji Hun; Kim, Yang In; Kim, Dae-Sung; Kang, Hoon Chul.

In: Brain and Development, 01.01.2017.

Research output: Contribution to journalArticle

Kim, Hyun Woo ; Quan, Zhejiu ; Kim, Young Beom ; Cheong, Eunji ; Kim, Heung Dong ; Cho, Minjung ; Jang, Jiho ; You, Young Rang ; Lee, Joon Soo ; Kim, Ji Hun ; Kim, Yang In ; Kim, Dae-Sung ; Kang, Hoon Chul. / Differential effects on sodium current impairments by distinct SCN1A mutations in GABAergic neurons derived from Dravet syndrome patients. In: Brain and Development. 2017.
@article{38cd20b6064344ed9feda55968591e4e,
title = "Differential effects on sodium current impairments by distinct SCN1A mutations in GABAergic neurons derived from Dravet syndrome patients",
abstract = "Background: We investigated how two distinct mutations in SCN1A differentially affect electrophysiological properties of the patient-derived GABAergic neurons and clinical severities in two Dravet syndrome (DS) patients. Materials and Methods: We established induced pluripotent stem cells from two DS patients with different mutations in SCN1A and subsequently differentiated them into forebrain GABAergic neurons. Functionality of differentiated GABAergic neurons was examined by electrophysiological recordings. Results: DS-1 patient had a missense mutation, c.4261G > T [GenBank: NM_006920.4] and DS-2 patient had a nonsense frameshift mutation, c.3576_3580 del TCAAA [GenBank: NM_006920.4]. Clinically, contrary to our expectations, DS-1 patient had more severe symptoms including frequency of seizure episodes and the extent of intellectual ability penetration than DS-2 patient. Electrophysiologic recordings showed significantly lower sodium current density and reduced action potential frequency at strong current injection (>60 pA) in GABAergic neurons derived from both. Intriguingly, unique genetic alterations of SCN1A differentially impacted electrophysiological impairment of the neurons, and the impairment's extent corresponded with the symptomatic severity of the donor from which the iPSCs were derived. Conclusion: Our results suggest the possibility that patient-derived iPSCs may provide a reliable in vitro system that reflects clinical severities in individuals with DS.",
keywords = "Dravet syndrome, Induced pluripotent stem cell, Voltage-gated sodium channel",
author = "Kim, {Hyun Woo} and Zhejiu Quan and Kim, {Young Beom} and Eunji Cheong and Kim, {Heung Dong} and Minjung Cho and Jiho Jang and You, {Young Rang} and Lee, {Joon Soo} and Kim, {Ji Hun} and Kim, {Yang In} and Dae-Sung Kim and Kang, {Hoon Chul}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.braindev.2017.12.002",
language = "English",
journal = "Brain and Development",
issn = "0387-7604",
publisher = "Elsevier",

}

TY - JOUR

T1 - Differential effects on sodium current impairments by distinct SCN1A mutations in GABAergic neurons derived from Dravet syndrome patients

AU - Kim, Hyun Woo

AU - Quan, Zhejiu

AU - Kim, Young Beom

AU - Cheong, Eunji

AU - Kim, Heung Dong

AU - Cho, Minjung

AU - Jang, Jiho

AU - You, Young Rang

AU - Lee, Joon Soo

AU - Kim, Ji Hun

AU - Kim, Yang In

AU - Kim, Dae-Sung

AU - Kang, Hoon Chul

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Background: We investigated how two distinct mutations in SCN1A differentially affect electrophysiological properties of the patient-derived GABAergic neurons and clinical severities in two Dravet syndrome (DS) patients. Materials and Methods: We established induced pluripotent stem cells from two DS patients with different mutations in SCN1A and subsequently differentiated them into forebrain GABAergic neurons. Functionality of differentiated GABAergic neurons was examined by electrophysiological recordings. Results: DS-1 patient had a missense mutation, c.4261G > T [GenBank: NM_006920.4] and DS-2 patient had a nonsense frameshift mutation, c.3576_3580 del TCAAA [GenBank: NM_006920.4]. Clinically, contrary to our expectations, DS-1 patient had more severe symptoms including frequency of seizure episodes and the extent of intellectual ability penetration than DS-2 patient. Electrophysiologic recordings showed significantly lower sodium current density and reduced action potential frequency at strong current injection (>60 pA) in GABAergic neurons derived from both. Intriguingly, unique genetic alterations of SCN1A differentially impacted electrophysiological impairment of the neurons, and the impairment's extent corresponded with the symptomatic severity of the donor from which the iPSCs were derived. Conclusion: Our results suggest the possibility that patient-derived iPSCs may provide a reliable in vitro system that reflects clinical severities in individuals with DS.

AB - Background: We investigated how two distinct mutations in SCN1A differentially affect electrophysiological properties of the patient-derived GABAergic neurons and clinical severities in two Dravet syndrome (DS) patients. Materials and Methods: We established induced pluripotent stem cells from two DS patients with different mutations in SCN1A and subsequently differentiated them into forebrain GABAergic neurons. Functionality of differentiated GABAergic neurons was examined by electrophysiological recordings. Results: DS-1 patient had a missense mutation, c.4261G > T [GenBank: NM_006920.4] and DS-2 patient had a nonsense frameshift mutation, c.3576_3580 del TCAAA [GenBank: NM_006920.4]. Clinically, contrary to our expectations, DS-1 patient had more severe symptoms including frequency of seizure episodes and the extent of intellectual ability penetration than DS-2 patient. Electrophysiologic recordings showed significantly lower sodium current density and reduced action potential frequency at strong current injection (>60 pA) in GABAergic neurons derived from both. Intriguingly, unique genetic alterations of SCN1A differentially impacted electrophysiological impairment of the neurons, and the impairment's extent corresponded with the symptomatic severity of the donor from which the iPSCs were derived. Conclusion: Our results suggest the possibility that patient-derived iPSCs may provide a reliable in vitro system that reflects clinical severities in individuals with DS.

KW - Dravet syndrome

KW - Induced pluripotent stem cell

KW - Voltage-gated sodium channel

UR - http://www.scopus.com/inward/record.url?scp=85039703865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039703865&partnerID=8YFLogxK

U2 - 10.1016/j.braindev.2017.12.002

DO - 10.1016/j.braindev.2017.12.002

M3 - Article

JO - Brain and Development

JF - Brain and Development

SN - 0387-7604

ER -